A Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Under Fasting Conditions

NCT06487416 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Tiotropium Bromide Inhalation Powder
DRUG: Spiriva®Handihaler®

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.